Table 1.
Comparison between HCM subjects and controls.
| HCM subjects (n = 30) |
Controls (n = 10) |
p | |
|---|---|---|---|
| Men | 20 (67%) | 5 (50%) | 0.35 |
| Age, years | 61 ± 12 | 56 ± 13 | 0.30 |
| Body mass index | 29.3 ± 4.9 | 25.3 ± 3.6 | 0.052 |
| Height, cm | 168 ± 10 | 167 ± 11 | 0.84 |
| Systolic blood pressure, mmHg | 136 ± 15 | 133 ± 18 | 0.56 |
| Von Willebrand factor rag | 152 ± 63 | 134 ± 35 | 0.96 |
| Abnormal flow mediated dilatation (value < 7%) | 20 (67%) | 4 (40%) | 0.14 |
| Abnormal venous filling index (value > 2) | 5 (17%) | 1 (10%) | 0.61 |
| Abnormal venous residual volume fraction (value > 35%) | 9 (30%) | 0 (0%) | 0.049 |
| Venous ejection fraction, % | 59 ± 15 | 63 ± 19 | 0.68 |
Data are expressed in mean ± SD or n (%), HCM = hypertrophic cardiomyopathy.